Salemonline Journal

Thyroid Eye Disease Market is Projected to Boost at a Moderate Growth Rate by (2022-2032) – Evaluated by DelveInsight | Key Companies – Viridian Therapeutics, Novartis, Immunovant Sciences GmbH

 Breaking News
  • No posts were found

Thyroid Eye Disease Market is Projected to Boost at a Moderate Growth Rate by (2022-2032) – Evaluated by DelveInsight | Key Companies – Viridian Therapeutics, Novartis, Immunovant Sciences GmbH

September 09
22:21 2022
Thyroid Eye Disease Market is Projected to Boost at a Moderate Growth Rate by (2022-2032) - Evaluated by DelveInsight | Key Companies -  Viridian Therapeutics, Novartis, Immunovant Sciences GmbH
DelveInsight’s “Thyroid Eye Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Thyroid Eye Disease, historical and forecasted epidemiology as well as the Thyroid Eye Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Thyroid Eye Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Thyroid Eye Disease pipeline products will significantly revolutionize the Thyroid Eye Disease market dynamics.  

 

DelveInsight’sThyroid Eye Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Thyroid Eye Disease, historical and forecasted epidemiology as well as the Thyroid Eye Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. 

 

Thyroid Eye Disease Overview

Thyroid eye disease (TED) is a complex orbital inflammatory disease that can be sight-threatening, debilitating, and disfiguring. TED is also known as Graves’ ophthalmopathy, named after Robert J. Graves, an Irish physician who first described thyrotoxicosis in a woman presenting with goiter, rapid heartbeat, and exophthalmos.

Thyroid Eye Disease Symptoms  

Dry eyes, wet eyes, red eyes, bulging eyes, a “stare,” double vision, difficulty closing the eyelids, and visual issues are thyroid eye disease symptoms. According to research, an autoimmune condition is the root cause of thyroid disease and thyroid eye disease. 

 

Some of the key facts of the Thyroid Eye Disease Market Report: 

  • The Thyroid Eye Disease market size is anticipated to grow with a significant CAGR during the study period (2019-2032)  
  • According to NORD, the exact prevalence (i.e., the number of people who have a disorder in a specific population at a specific time) of thyroid eye disease is not known 
  • According to a study by Bahn et al., in approximately 40% of patients with Thyroid Eye Disease, the ocular and systemic symptoms have simultaneous onset
  • Key Thyroid Eye Disease Companies: Viridian Therapeutics, Novartis, Immunovant Sciences GmbH, and others
  • Key Thyroid Eye Disease Therapies: VRDN-001, Secukinumab, IMVT-1401, and others 
  • The Thyroid Eye Disease epidemiology based on gender in the 7Mm analyzed that the incidence of Thyroid Eye Disease is 16 per 100,000 females and 2.9 per 100,000 males with an approximate prevalence of 0.25% with no significant ethnic predisposition

 

Get a Free sample for the Thyroid Eye Disease Market Report 

 

Key benefits of the Thyroid Eye Disease Market report:

  1. Thyroid Eye Disease market report covers a descriptive overview and comprehensive insight of the Thyroid Eye Disease Epidemiology and Thyroid Eye Disease market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Thyroid Eye Disease market report provides insights on the current and emerging therapies.
  3. Thyroid Eye Disease market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Thyroid Eye Disease market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Thyroid Eye Disease market.

 

Discover more about therapies set to grab major Thyroid Eye Disease market share @ Thyroid Eye Disease market forecast

 

Thyroid Eye Disease Epidemiology Segmentation:

The Thyroid Eye Disease market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Thyroid Eye Disease
  • Prevalent Cases of Thyroid Eye Disease by severity
  • Gender-specific Prevalence of Thyroid Eye Disease
  • Diagnosed Cases of Episodic and Chronic Thyroid Eye Disease 

 

Thyroid Eye Disease Market  

The dynamics of the Thyroid Eye Disease market are anticipated to change in the coming years owing to the expected launch of emerging therapies, and others during the forecasted period 2019-2032. 

“The rise in the number of patients with thyroid disorders, favorable reimbursement policies for treatment, and increase in awareness about the complications associated with thyroid disorders are the major drivers of the Graves’ disease market. Increasing iodine disorder and thyroid tumors screening are one of the leading factors fueling the growth of the market.”

 

Download the report to understand which factors are driving Thyroid Eye Disease epidemiology trends @ Thyroid Eye Disease Epidemiological Insights 

 

Thyroid Eye Disease Therapies

  • VRDN-001
  • Secukinumab
  • IMVT-1401

 

Thyroid Eye Disease Key Companies 

  • Viridian Therapeutics
  • Novartis
  • Immunovant Sciences GmbH

 

Scope of the Thyroid Eye Disease Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Thyroid Eye Disease Companies: Viridian Therapeutics, Novartis, Immunovant Sciences GmbH, and others
  • Key Thyroid Eye Disease Therapies: VRDN-001, Secukinumab, IMVT-1401, and others
  • Therapeutic Assessment: Thyroid Eye Disease current marketed and Thyroid Eye Disease emerging therapies
  • Thyroid Eye Disease Market Dynamics:  Thyroid Eye Disease market drivers and barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Unmet Needs, KOL’s views, Analyst’s views, Thyroid Eye Disease  Market Access and Reimbursement 

 

Table of Contents 

1. Thyroid Eye Disease Market Report Introduction

2. Executive Summary for Thyroid Eye Disease

3. SWOT analysis of Thyroid Eye Disease

4. Thyroid Eye Disease Patient Share (%) Overview at a Glance

5. Thyroid Eye Disease Market Overview at a Glance

6. Thyroid Eye Disease Disease Background and Overview

7. Thyroid Eye Disease Epidemiology and Patient Population

8. Country-Specific Patient Population of Thyroid Eye Disease 

9. Thyroid Eye Disease Current Treatment and Medical Practices

10. Thyroid Eye Disease Unmet Needs

11. Thyroid Eye Disease Emerging Therapies

12. Thyroid Eye Disease Market Outlook

13. Country-Wise Thyroid Eye Disease Market Analysis (2019–2032)

14. Thyroid Eye Disease Market Access and Reimbursement of Therapies

15. Thyroid Eye Disease Market drivers

16. Thyroid Eye Disease Market barriers

17.  Thyroid Eye Disease Appendix

18. Thyroid Eye Disease Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Thyroid Eye Disease treatment, visit @ Thyroid Eye Disease Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles